Genital Diseases, Female  >>  gemcitabine  >>  Phase 1
Welcome,         Profile    Billing    Logout  

12 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
gemcitabine / Generic mfg.
NCT01016054: A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer

Terminated
1b
4
US
AGS-8M4, Pegylated liposomal doxorubicin (PLD), gemcitabine, carboplatin
Astellas Pharma Inc, Agensys, Inc.
Carcinoma, Ovarian Cancer, Ovarian Diseases, Ovarian Neoplasms
04/10
04/10
NCT00003358: Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Completed
1
24
US
chemotherapy, cisplatin, gemcitabine hydrochloride
Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI)
Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
01/01
 
NCT00004082: Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors

Completed
1
US
carboplatin, docetaxel, gemcitabine hydrochloride
Beth Israel Deaconess Medical Center
Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
09/03
12/10
NCT00003382: Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer

Terminated
1
US
filgrastim, gemcitabine hydrochloride, topotecan hydrochloride
Gynecologic Oncology Group, National Cancer Institute (NCI)
Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
04/06
 
NCT00068549: Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer

Completed
1
13
US
Gemcitabine Hydrochloride, dFdC, dFdCyd, Cisplatin, Radiation Therapy, Cancer Radiotherapy, Irradiate, Irradiated, Irradiation, RT, Internal Radiation Therapy, Brachytherapy, Internal Radiation, Internal Radiation Brachytherapy, Radiation Brachytherapy
Gynecologic Oncology Group, National Cancer Institute (NCI)
Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Small Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
01/08
 
NCT00620295: Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors

Completed
1
17
US
bortezomib, Velcade, gemcitabine hydrochloride, Gemzar
Masonic Cancer Center, University of Minnesota
Breast Cancer, Colorectal Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Sarcoma
02/09
10/09
NCT00410553: Eribulin Mesylate and Gemcitabine Hydrochloride in Treating Patients With Metastatic Solid Tumors or Solid Tumors That Cannot be Removed by Surgery

Completed
1
45
Canada
Eribulin Mesylate, B1939 Mesylate, E7389, ER-086526, Halaven, Halichondrin B Analog, Gemcitabine Hydrochloride, dFdCyd, Difluorodeoxycytidine Hydrochloride, Gemzar, LY-188011, LY188011
National Cancer Institute (NCI)
Adult Solid Neoplasm, Recurrent Ovarian Carcinoma, Recurrent Uterine Corpus Carcinoma, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Uterine Corpus Cancer AJCC v7, Stage IV Ovarian Cancer AJCC v6 and v7, Stage IV Uterine Corpus Cancer AJCC v7
10/12
10/12
NCT01279291: Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer

Terminated
1
22
US
KHK2866, Gemcitabine and Carboplatin, Gemzar, Paraplatin, paclitaxel, Taxol, pegylated liposomal doxorubicin, Doxil
Kyowa Kirin Co., Ltd., Kyowa Hakko Kirin Pharma, Inc.
Neoplasms, Ovarian Neoplasms, Fallopian Tube Neoplasms, Primary Peritoneal Neoplasm
11/12
11/12
NCT01652794: Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer

Completed
1
12
US
stereotactic body radiation therapy, SBRT, stereotactic radiation therapy, stereotactic radiotherapy, carboplatin, Carboplat, CBDCA, JM-8, Paraplat, Paraplatin, gemcitabine hydrochloride, dFdC, difluorodeoxycytidine hydrochloride, gemcitabine, Gemzar, laboratory biomarker analysis, pharmacogenomic studies, Pharmacogenomic Study
Case Comprehensive Cancer Center, National Cancer Institute (NCI)
Leydig Cell Tumor, Ovarian Sarcoma, Ovarian Stromal Cancer, Pseudomyxoma Peritonei, Recurrent Cervical Cancer, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor, Recurrent Primary Peritoneal Cavity Cancer, Recurrent Uterine Sarcoma, Recurrent Vaginal Cancer, Recurrent Vulvar Cancer
05/14
03/15
NCT02728492: Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Completed
1
51
RoW
Quisinostat, JNJ-26481585, Paclitaxel, Carboplatin, Gemcitabine, Cisplatin
NewVac LLC, Janssen Pharmaceutica N.V., Belgium
Non-small Cell Lung Cancer, Epithelial Ovarian Cancer
12/15
01/16
NCT02275039: p53MVA Vaccine and Gemcitabine Hydrochloride in Treating Patients With Recurrent Ovarian Epithelial Cancer

Completed
1
12
US
modified vaccinia virus ankara vaccine expressing p53, MVA-p53 vaccine, MVAp53 vaccine, gemcitabine hydrochloride, dFdC, difluorodeoxycytidine hydrochloride, gemcitabine, Gemzar, laboratory biomarker analysis
City of Hope Medical Center, National Cancer Institute (NCI)
Recurrent Ovarian Epithelial Cancer, Recurrent Fallopian Tube Carcinoma, Recurrent Primary Peritoneal Carcinoma
04/18
04/18
NCT02046421: Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Completed
1
31
US
mifepristone, Mifegyne, Mifeprex, RU-38486, carboplatin, Carboplat, CBDCA, JM-8, Paraplat, Paraplatin, gemcitabine hydrochloride, dFdC, difluorodeoxycytidine hydrochloride, gemcitabine, Gemzar, laboratory biomarker analysis, pharmacological study, pharmacological studies
University of Chicago, National Cancer Institute (NCI)
Male Breast Cancer, Recurrent Breast Cancer, Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
05/18
05/18

Download Options